person · Reporting owner
Palmieri Valerie Barber
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspira Women's Health Inc.awh · Entity 7871 | Director · Executive Chair | May 16, 2022 | May 18, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspira Women's Health Inc.
Report date May 16, 2022 · Filed May 18, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 267,088 |
Reported balance
After 2022-05-16 transaction · row 1
1 source rowRow 1 · 2022-05-16 · Purchase · Acquired 43,994 · Balance 267,088 F1: The purchase price reported in column 4 is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.4928 to $0.6000 per share. The reporting person undertakes to provide to Aspira Women's Health Inc., any security holder of Aspira Women's Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The purchase price reported in column 4 is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.4928 to $0.6000 per share. The reporting person undertakes to provide to Aspira Women's Health Inc., any security holder of Aspira Women's Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2022 Filed May 18, 2022 13:22 UTC | Aspira Women's Health Inc. awh · Entity 7871 | PurchaseCommon Stock | 43,994 | $0.57 | $24,918.20 |
DisclosureSEC source: 0001623017-22-000001 · primary_doc.xml · nonDerivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · Executive Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,088 F1 · price: The purchase price reported in column 4 is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.4928 to $0.6000 per share. The reporting person undertakes to provide to Aspira Women's Health Inc., any security holder of Aspira Women's Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. Read SEC document |
| March 19, 2021 Filed Mar 23, 2021 21:51 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 450,000 | $0.00 Strike: $7.40 | $0.00 |
DisclosureSEC source: 0001623017-21-000001 · primary_doc.xml · derivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2031-03-19 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 19, 2022. Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:40 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | OtherWarrants to acquire Common Stock · Derivative | 7,531 | $0.00 Strike: $1.80 | $0.00 |
DisclosureSEC source: 0001623017-20-000003 · primary_doc.xml · derivative · entry 2 Palmieri Valerie Barber · CIK 0001623017 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,531 shares Expires 2020-06-09 Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:40 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | OtherCommon Stock | 7,531 | $1.80 | $13,555.80 |
DisclosureSEC source: 0001623017-20-000003 · primary_doc.xml · nonDerivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,094 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 01:15 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 125,000 | $0.00 Strike: $0.47 | $0.00 |
DisclosureSEC source: 0001623017-20-000002 · primary_doc.xml · derivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: COMMON STOCK · 125,000 shares Expires 2029-01-08 F1 · derivative.exercise_date: An option to purchase 250,000 shares of common stock was granted to the reporting person on 1/8/19, subject to the satisfaction of certain performance conditions. On 6/1/20, a portion of the performance conditions were deemed to have been met, resulting in 125,000 shares earned. The remaining option to purchase 125,000 shares was canceled. Half of the achieved portion of the option grant is immediately exercisable and the remaining 50% will vest on 3/31/21. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:15 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $0.68 | $0.00 |
DisclosureSEC source: 0001623017-20-000001 · primary_doc.xml · derivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2030-03-19 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 19, 2021. Read SEC document |
| June 28, 2019 Filed Jul 1, 2019 20:32 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseCommon Stock, par value $0.001 per share | 37,500 | $0.80 | $30,000.00 |
DisclosureSEC source: 0001623017-19-000002 · primary_doc.xml · nonDerivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,563 Read SEC document |
| March 26, 2019 Filed Mar 29, 2019 00:13 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 450,000 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001623017-19-000001 · primary_doc.xml · derivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2029-03-26 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 26, 2020. Read SEC document |
| August 17, 2018 Filed Aug 20, 2018 20:29 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseCommon Stock, par value $0.001 per share | 97,000 | $0.52 | $50,440.00 |
DisclosureSEC source: 0001623017-18-000004 · primary_doc.xml · nonDerivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,063 F1 · price: The purchase reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.5014 to $0.5335 per share. The reporting person undertakes to provide to Vermillion, any security holder of Vermillion or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 20:50 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseCommon Stock, par value $0.001 per share | 19,100 | $0.51 | $9,741.00 |
DisclosureSEC source: 0001623017-18-000003 · primary_doc.xml · nonDerivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,063 Read SEC document |
| April 13, 2018 Filed Apr 17, 2018 20:48 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $0.89 | $0.00 |
DisclosureSEC source: 0001623017-18-000002 · primary_doc.xml · derivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2026-11-08 F1 · derivative.exercise_date: An option to purchase 350,000 shares of common stock was granted to the reporting person on 11/8/16, subject to the satisfaction of certain performance conditions. On 4/13/18, a portion of the performance conditions were deemed to have been met, resulting in 100,000 shares earned. The remaining option to purchase 250,000 shares was canceled. Half of the achieved portion of the option grant is immediately exercisable and the remaining 50% will vest on 12/31/18. Read SEC document |
| April 13, 2018 Filed Apr 17, 2018 20:42 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantEmployee Stock Option (Right to Buy) · Derivative | 450,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001623017-18-000001 · primary_doc.xml · derivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2028-04-13 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on April 13, 2019. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 21:12 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseCommon Stock, par value $0.001 | 685 | $1.46 | $1,000.10 |
DisclosureSEC source: 0001623017-17-000009 · primary_doc.xml · nonDerivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,963 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2017. Read SEC document |
| October 16, 2017 Filed Oct 18, 2017 20:10 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseCommon Stock, par value $0.001 | 694 | $1.44 | $999.36 |
DisclosureSEC source: 0001623017-17-000008 · primary_doc.xml · nonDerivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,278 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2017. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 20:09 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseCommon Stock, par value $0.001 | 719 | $1.39 | $999.41 |
DisclosureSEC source: 0001623017-17-000007 · primary_doc.xml · nonDerivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,584 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2017. Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 20:03 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseCommon Stock, par value $0.001 | 768 | $1.30 | $998.40 |
DisclosureSEC source: 0001623017-17-000006 · primary_doc.xml · nonDerivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,865 F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 25, 2017. Read SEC document |
| May 17, 2017 Filed May 18, 2017 20:42 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseCommon Stock, par value $0.001 | 555 | $1.80 | $999.00 |
DisclosureSEC source: 0001623017-17-000005 · primary_doc.xml · nonDerivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,097 Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 21:14 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 450,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001623017-17-000004 · primary_doc.xml · derivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President and Chief Executive 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2027-03-23 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 23, 2018. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:43 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseWarrants (Right to buy) · Derivative | 7,531 | $0.13 Strike: $1.80 | $941.38 |
DisclosureSEC source: 0001623017-17-000003 · primary_doc.xml · derivative · entry 2 Palmieri Valerie Barber · CIK 0001623017 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,531 Underlying: Common Stock · 7,531 shares Expires 2022-02-17 Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:43 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | PurchaseCommon Stock, par value $0.001 | 10,042 | $1.40 | $14,058.80 |
DisclosureSEC source: 0001623017-17-000003 · primary_doc.xml · nonDerivative · entry 1 Palmieri Valerie Barber · CIK 0001623017 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,542 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.